{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:45:13Z","timestamp":1790459113164,"version":"4.1.0"},"reference-count":129,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.vph.2012.09.001","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T20:03:21Z","timestamp":1347480201000},"page":"211-218","source":"Crossref","is-referenced-by-count":24,"title":["Cyclic guanosine monophosphate signalling pathway in pulmonary arterial hypertension"],"prefix":"10.1016","volume":"58","author":[{"given":"Chien-nien","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2012.09.001_bb0005","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.RES.0000111804.34509.94","article-title":"Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats","volume":"94","author":"Abe","year":"2004","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0010","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1164\/ajrccm\/148.2.519","article-title":"Circulating immunoreactive endothelin-1 in children with pulmonary hypertension. Association with acute hypoxic pulmonary vasoreactivity","volume":"148","author":"Allen","year":"1993","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.vph.2012.09.001_bb0015","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0306-3623(96)00275-3","article-title":"Effects of natriuretic peptides on vascular smooth-muscle cells derived from different vascular beds","volume":"28","author":"Arjona","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.vph.2012.09.001_bb0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.vph.2012.09.001_bb0030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1164\/rccm.200801-121OC","article-title":"Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension","volume":"178","author":"Baliga","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0025","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/CIRCULATIONAHA.112.100586","article-title":"Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase","volume":"125","author":"Baliga","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrm911","article-title":"Cyclic nucleotide research \u2013 still expanding after half a century","volume":"3","author":"Beavo","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.vph.2012.09.001_bb0040","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/hrt.73.1.65","article-title":"Continuous low dose inhaled nitric oxide for treatment of severe pulmonary hypertension after cardiac surgery in paediatric patients","volume":"73","author":"Beghetti","year":"1995","journal-title":"Br. Heart J."},{"key":"10.1016\/j.vph.2012.09.001_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(98)09423-9","article-title":"Endothelin antagonists","volume":"353","author":"Benigni","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2012.09.001_bb0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12035-007-0025-y","article-title":"Function and dysfunction of CNG channels: insights from channelopathies and mouse models","volume":"35","author":"Biel","year":"2007","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0055","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nchembio704","article-title":"A molecular basis for NO selectivity in soluble guanylate cyclase","volume":"1","author":"Boon","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.vph.2012.09.001_bb0060","doi-asserted-by":"crossref","first-page":"H524","DOI":"10.1152\/ajpheart.00543.2008","article-title":"Pulmonary vasodilator responses to sodium nitrite are mediated by an allopurinol-sensitive mechanism in the rat","volume":"296","author":"Casey","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0065","first-page":"269","article-title":"Brain natriuretic peptide in pulmonary arterial hypertension: biomarker and potential therapeutic agent","volume":"3","author":"Casserly","year":"2009","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.vph.2012.09.001_bb0070","doi-asserted-by":"crossref","first-page":"13248","DOI":"10.1073\/pnas.182225899","article-title":"Adenoviral gene transfer of endothelial nitric-oxide synthase (eNOS) partially restores normal pulmonary arterial pressure in eNOS-deficient mice","volume":"99","author":"Champion","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2012.09.001_bb0075","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.coph.2011.09.002","article-title":"PDE1 isozymes, key regulators of pathological vascular remodeling","volume":"11","author":"Chan","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.vph.2012.09.001_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijcard.2003.12.023","article-title":"Efficacy and optimal dose of sildenafil in primary pulmonary hypertension","volume":"99","author":"Chockalingam","year":"2005","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1056\/NEJM199207093270202","article-title":"An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension","volume":"327","author":"Christman","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0095","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1046\/j.1432-1327.2000.01297.x","article-title":"Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities","volume":"267","author":"Corbin","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.vph.2012.09.001_bb0090","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.bbrc.2005.06.183","article-title":"High lung PDE5: a strong basis for treating pulmonary hypertension with PDE5 inhibitors","volume":"334","author":"Corbin","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2012.09.001_bb0100","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1146\/annurev.physiol.68.040104.134728","article-title":"CNG and HCN channels: two peas, one pod","volume":"68","author":"Craven","year":"2006","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0105","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1161\/CIRCULATIONAHA.111.038919","article-title":"Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease","volume":"125","author":"Cunnington","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9149(00)80080-6","article-title":"Pulmonary vasodilatory effects of 12 and 60 parts per million inhaled nitric oxide in children with ventricular septal defect","volume":"75","author":"Day","year":"1995","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0115","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1183\/09031936.00002007","article-title":"Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3\/4 inhibition","volume":"31","author":"Dony","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2012.09.001_bb0120","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-5793(93)81151-O","article-title":"Core sequence of ATP regulatory module in receptor guanylate cyclases","volume":"315","author":"Duda","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.vph.2012.09.001_bb0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.105.581405","article-title":"Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling","volume":"113","author":"Dumitrascu","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0130","doi-asserted-by":"crossref","first-page":"H707","DOI":"10.1152\/ajpheart.00677.2001","article-title":"Ventricular expression of natriuretic peptides in Npr1(\u2212\/\u2212) mice with cardiac hypertrophy and fibrosis","volume":"283","author":"Ellmers","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0135","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1210\/en.133.6.2474","article-title":"Cellular mechanism of natriuretic peptides-induced inhibition of endothelin-1 biosynthesis in rat endothelial cells","volume":"133","author":"Emori","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.vph.2012.09.001_bb0140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrd2038","article-title":"NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential","volume":"5","author":"Evgenov","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vph.2012.09.001_bb0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/rr44","article-title":"Role of endothelin-1 in lung disease","volume":"2","author":"Fagan","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0150","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/01.RES.0000100390.68771.CC","article-title":"Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice","volume":"93","author":"Feil","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0155","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2741\/1684","article-title":"Molecular properties of mammalian proteins that interact with cGMP: protein kinases, cation channels, phosphodiesterases, and multi-drug anion transporters","volume":"10","author":"Francis","year":"2005","journal-title":"Front. Biosci."},{"key":"10.1016\/j.vph.2012.09.001_bb0165","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Galie","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0160","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","article-title":"Tadalafil therapy for pulmonary arterial hypertension","volume":"119","author":"Galie","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0170","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurheartj\/ehp022","article-title":"A meta-analysis of randomized controlled trials in pulmonary arterial hypertension","volume":"30","author":"Galie","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2012.09.001_bb0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","article-title":"Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension","volume":"136","author":"Ghofrani","year":"2002","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0180","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0735-1097(03)00555-2","article-title":"Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension","volume":"42","author":"Ghofrani","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0175","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1183\/09031936.00182909","article-title":"Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study","volume":"36","author":"Ghofrani","year":"2010","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2012.09.001_bb0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension","volume":"333","author":"Giaid","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0195","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0200","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1164\/rccm.200412-1684OC","article-title":"Decreased exhaled nitric oxide in pulmonary arterial hypertension: response to bosentan therapy","volume":"172","author":"Girgis","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Pt 2","key":"10.1016\/j.vph.2012.09.001_bb0205","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1042\/bj2820533","article-title":"A structural motif that defines the ATP-regulatory module of guanylate cyclase in atrial natriuretic factor signalling","volume":"282","author":"Goraczniak","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.vph.2012.09.001_bb0210","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1172\/JCI45023","article-title":"Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice","volume":"121","author":"Hara","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2012.09.001_bb0215","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3181\/00379727-199-43342","article-title":"Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells","volume":"199","author":"Hassoun","year":"1992","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0220","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jpedsurg.2006.12.026","article-title":"Intravenous vasoactive intestinal polypeptide lowers pulmonary-to-systemic vascular resistance ratio in a neonatal piglet model of pulmonary arterial hypertension","volume":"42","author":"Haydar","year":"2007","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.vph.2012.09.001_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R400035200","article-title":"The biology of cyclic GMP-dependent protein kinases","volume":"280","author":"Hofmann","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0230","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/CIRCULATIONAHA.109.911818","article-title":"Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era","volume":"122","author":"Humbert","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0235","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nm1109","article-title":"Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator","volume":"10","author":"Hunter","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0240","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1253\/circj.70.174","article-title":"Beneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertension","volume":"70","author":"Ishikura","year":"2006","journal-title":"Circ. J."},{"key":"10.1016\/j.vph.2012.09.001_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/CS19980070","article-title":"Increased plasma levels of adrenomedullin in patients with pulmonary hypertension","volume":"96","author":"Kakishita","year":"1999","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.vph.2012.09.001_bb0250","doi-asserted-by":"crossref","first-page":"7236","DOI":"10.1016\/S0021-9258(17)38380-1","article-title":"Soluble guanylate cyclase from rat lung exists as a heterodimer","volume":"261","author":"Kamisaki","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0255","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cardiores.2007.02.031","article-title":"Phosphodiesterase regulation of nitric oxide signaling","volume":"75","author":"Kass","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0260","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1161\/01.ATV.0000184759.91369.f8","article-title":"Adrenomedullin: a protective factor for blood vessels","volume":"25","author":"Kato","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2012.09.001_bb0265","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1152\/physrev.00008.2002","article-title":"Cyclic nucleotide-gated ion channels","volume":"82","author":"Kaupp","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2012.09.001_bb0270","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1161\/01.CIR.0000162470.26840.89","article-title":"Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension","volume":"111","author":"Khoo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0275","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/ers.11.38","article-title":"Tadalafil for the treatment of pulmonary arterial hypertension","volume":"5","author":"Klinger","year":"2011","journal-title":"Expert Rev. Respir. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0285","first-page":"L868","article-title":"Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice","volume":"276","author":"Klinger","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1378\/chest.129.2.417","article-title":"Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension","volume":"129","author":"Klinger","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.vph.2012.09.001_bb0290","doi-asserted-by":"crossref","first-page":"34301","DOI":"10.1074\/jbc.274.48.34301","article-title":"Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells","volume":"274","author":"Komalavilas","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/1097-4652(200101)186:1<1::AID-JCP1012>3.0.CO;2-D","article-title":"Molecular pathways of cyclic nucleotide-induced inhibition of arterial smooth muscle cell proliferation","volume":"186","author":"Koyama","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0300","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.RES.0000094745.28948.4D","article-title":"Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A","volume":"93","author":"Kuhn","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0305","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0014-5793(87)80256-9","article-title":"Participation of adenosine 5'-triphosphate in the activation of membrane-bound guanylate cyclase by the atrial natriuretic factor","volume":"219","author":"Kurose","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/j.vph.2012.09.001_bb0320","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.125.2.580","article-title":"Hemodynamic response to sildenafil, nitric oxide, and iloprost in primary pulmonary hypertension","volume":"125","author":"Leuchte","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.vph.2012.09.001_bb0315","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1183\/09031936.00050008","article-title":"Inhalation of vasoactive intestinal peptide in pulmonary hypertension","volume":"32","author":"Leuchte","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2012.09.001_bb0325","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nrd2466","article-title":"The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics","volume":"7","author":"Lundberg","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.vph.2012.09.001_bb0335","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/sj.emboj.7601521","article-title":"NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism","volume":"26","author":"Ma","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.vph.2012.09.001_bb0330","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1074\/jbc.M706218200","article-title":"PAS-mediated dimerization of soluble guanylyl cyclase revealed by signal transduction histidine kinase domain crystal structure","volume":"283","author":"Ma","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0340","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ahj.2009.11.028","article-title":"Systematic review of trials using vasodilators in pulmonary arterial hypertension: why a new approach is needed","volume":"159","author":"Macchia","year":"2010","journal-title":"Am. Heart J."},{"key":"10.1016\/j.vph.2012.09.001_bb0345","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0022-3565(24)37102-2","article-title":"Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension","volume":"283","author":"MacLean","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.vph.2012.09.001_bb0350","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1161\/01.CIR.0000127950.13380.FD","article-title":"Adrenomedullin can protect against pulmonary vascular remodeling induced by hypoxia","volume":"109","author":"Matsui","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0355","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/01.CIR.0000029100.82385.58","article-title":"Survival in primary pulmonary hypertension: the impact of epoprostenol therapy","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0360","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway","volume":"329","author":"Moncada","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0365","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0370","doi-asserted-by":"crossref","first-page":"L294","DOI":"10.1152\/ajplung.00190.2006","article-title":"Expression and activity of cAMP phosphodiesterase isoforms in pulmonary artery smooth muscle cells from patients with pulmonary hypertension: role for PDE1","volume":"292","author":"Murray","year":"2007","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0380","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/heart.84.6.653","article-title":"Haemodynamic and hormonal effects of adrenomedullin in patients with pulmonary hypertension","volume":"84","author":"Nagaya","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.vph.2012.09.001_bb0385","doi-asserted-by":"crossref","first-page":"H2125","DOI":"10.1152\/ajpheart.00548.2002","article-title":"Repeated inhalation of adrenomedullin ameliorates pulmonary hypertension and survival in monocrotaline rats","volume":"285","author":"Nagaya","year":"2003","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0375","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/01.CIR.0000109493.05849.14","article-title":"Effects of adrenomedullin inhalation on hemodynamics and exercise capacity in patients with idiopathic pulmonary arterial hypertension","volume":"109","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0390","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1161\/01.CIR.0000163268.32638.F4","article-title":"Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse","volume":"111","author":"Nandi","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0395","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.peptides.2007.12.006","article-title":"Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: comparison with C-reactive protein and adiponectin","volume":"29","author":"Nishida","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.vph.2012.09.001_bb0400","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrcardio.2011.104","article-title":"Treatment of pulmonary arterial hypertension with targeted therapies","volume":"8","author":"O'Callaghan","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0410","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/01.RES.0000261658.12024.18","article-title":"Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats","volume":"100","author":"Oka","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0405","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/bjp.2008.239","article-title":"Therapeutic potential of RhoA\/Rho kinase inhibitors in pulmonary hypertension","volume":"155","author":"Oka","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2012.09.001_bb0415","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1161\/01.RES.0000256354.95791.f1","article-title":"Overview of PDEs and their regulation","volume":"100","author":"Omori","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0420","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI17500","article-title":"Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension","volume":"111","author":"Petkov","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2012.09.001_bb0425","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1093\/emboj\/17.11.3045","article-title":"Defective smooth muscle regulation in cGMP kinase I-deficient mice","volume":"17","author":"Pfeifer","year":"1998","journal-title":"EMBO J."},{"key":"10.1016\/j.vph.2012.09.001_bb0430","doi-asserted-by":"crossref","first-page":"L103","DOI":"10.1152\/ajplung.00095.2004","article-title":"cAMP phosphodiesterase inhibitors potentiate effects of prostacyclin analogs in hypoxic pulmonary vascular remodeling","volume":"288","author":"Phillips","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0435","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/CIRCULATIONAHA.110.941484","article-title":"cAMP phosphodiesterase inhibitors increases nitric oxide production by modulating dimethylarginine dimethylaminohydrolases","volume":"123","author":"Pullamsetti","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/aps.2008.1","article-title":"Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts","volume":"30","author":"Rao","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.vph.2012.09.001_bb0445","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/01902148.2010.512972","article-title":"Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension","volume":"37","author":"Robbins","year":"2011","journal-title":"Exp. Lung Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0450","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/01.CIR.87.2.447","article-title":"Inhaled nitric oxide in congenital heart disease","volume":"87","author":"Roberts","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0460","doi-asserted-by":"crossref","first-page":"485","DOI":"10.7326\/0003-4819-112-7-485","article-title":"Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial","volume":"112","author":"Rubin","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0455","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0465","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/emboj\/cdg051","article-title":"PDE5 is converted to an activated state upon cGMP binding to the GAF A domain","volume":"22","author":"Rybalkin","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.vph.2012.09.001_bb0470","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCULATIONAHA.106.681718","article-title":"Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene","volume":"115","author":"Said","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0475","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000025576","article-title":"Does nitric oxide regulate smooth muscle cell proliferation? A critical appraisal","volume":"35","author":"Sarkar","year":"1998","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0480","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1172\/JCI35067","article-title":"Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation","volume":"118","author":"Sassi","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2012.09.001_bb0485","doi-asserted-by":"crossref","first-page":"21722","DOI":"10.1074\/jbc.M000753200","article-title":"Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle","volume":"275","author":"Sauzeau","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0490","doi-asserted-by":"crossref","first-page":"9472","DOI":"10.1074\/jbc.M212776200","article-title":"RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation","volume":"278","author":"Sauzeau","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0495","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1006\/bbrc.2000.4194","article-title":"cGMP-dependent protein kinase phosphorylates and inactivates RhoA","volume":"280","author":"Sawada","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2012.09.001_bb0510","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1164\/rccm.200302-282OC","article-title":"Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats","volume":"169","author":"Schermuly","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0515","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1161\/CIRCULATIONAHA.106.676809","article-title":"Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy","volume":"115","author":"Schermuly","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0520","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1183\/09031936.00114407","article-title":"Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension","volume":"32","author":"Schermuly","year":"2008","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.vph.2012.09.001_bb0500","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nrcardio.2011.87","article-title":"Mechanisms of disease: pulmonary arterial hypertension","volume":"8","author":"Schermuly","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0505","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/13543784.2011.565048","article-title":"Riociguat for the treatment of pulmonary hypertension","volume":"20","author":"Schermuly","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.vph.2012.09.001_bb0525","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/01.CIR.0000074226.20466.B1","article-title":"Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension","volume":"107","author":"Sebkhi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0530","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4097\/kjae.2010.58.1.4","article-title":"Nitric oxide and pulmonary hypertension","volume":"58","author":"Sim","year":"2010","journal-title":"Korean J. Anesthesiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0535","doi-asserted-by":"crossref","first-page":"521","DOI":"10.7326\/0003-4819-149-8-200810210-00004","article-title":"Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial","volume":"149","author":"Simonneau","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0545","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1161\/CIRCULATIONAHA.112.107821","article-title":"Nitrate-nitrite-nitric oxide pathway in pulmonary arterial hypertension therapeutics","volume":"125","author":"Sparacino-Watkins","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0550","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1161\/CIRCRESAHA.107.165779","article-title":"cGMP-dependent protein kinase I and smooth muscle relaxation: a tale of two isoforms","volume":"101","author":"Surks","year":"2007","journal-title":"Circ. Res."},{"issue":"Pt 1","key":"10.1016\/j.vph.2012.09.001_bb0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/0264-6021:3470001","article-title":"Tetrahydrobiopterin biosynthesis, regeneration and functions","volume":"347","author":"Thony","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.vph.2012.09.001_bb0560","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1164\/ajrccm.159.6.9804054","article-title":"Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension","volume":"159","author":"Tuder","year":"1999","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0565","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000047128","article-title":"Plasma cyclic guanosine monophosphate reflecting the severity of persistent pulmonary hypertension of the newborn","volume":"80","author":"Turanlahti","year":"2001","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.vph.2012.09.001_bb0570","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s12325-011-0005-5","article-title":"Prostacyclins in pulmonary arterial hypertension: the need for earlier therapy","volume":"28","author":"Vachiery","year":"2011","journal-title":"Adv. Ther."},{"key":"10.1016\/j.vph.2012.09.001_bb0575","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.V133595","article-title":"The MRP4\/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP","volume":"13","author":"van Aubel","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.vph.2012.09.001_bb0580","doi-asserted-by":"crossref","first-page":"9220","DOI":"10.1073\/pnas.95.16.9220","article-title":"Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors","volume":"95","author":"Vasquez-Vivar","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2012.09.001_bb0585","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00018-008-8525-0","article-title":"HCN channels: structure, cellular regulation and physiological function","volume":"66","author":"Wahl-Schott","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.vph.2012.09.001_bb0590","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/CIRCRESAHA.107.154351","article-title":"Rescue of cGMP kinase I knockout mice by smooth muscle specific expression of either isozyme","volume":"101","author":"Weber","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0595","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1161\/hh0102.103222","article-title":"cGMP-dependent protein kinase I mediates the negative inotropic effect of cGMP in the murine myocardium","volume":"90","author":"Wegener","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0600","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200411-1587OC","article-title":"Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells","volume":"172","author":"Wharton","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.vph.2012.09.001_bb0605","doi-asserted-by":"crossref","first-page":"17664","DOI":"10.1074\/jbc.M212723200","article-title":"Characterization of the MRP4- and MRP5-mediated transport of cyclic nucleotides from intact cells","volume":"278","author":"Wielinga","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0610","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/pgmj.2007.066555","article-title":"New drug targets for pulmonary hypertension: Rho GTPases in pulmonary vascular remodelling","volume":"84","author":"Wojciak-Stothard","year":"2008","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.vph.2012.09.001_bb0615","doi-asserted-by":"crossref","first-page":"13519","DOI":"10.1073\/pnas.1936024100","article-title":"A proatherogenic role for cGMP-dependent protein kinase in vascular smooth muscle cells","volume":"100","author":"Wolfsgruber","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2012.09.001_bb0620","doi-asserted-by":"crossref","first-page":"25804","DOI":"10.1074\/jbc.273.40.25804","article-title":"Superoxide generation from endothelial nitric-oxide synthase. A Ca2+\/calmodulin-dependent and tetrahydrobiopterin regulatory process","volume":"273","author":"Xia","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0625","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCRESAHA.106.144501","article-title":"cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology","volume":"100","author":"Zaccolo","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2012.09.001_bb0630","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.tips.2011.02.019","article-title":"Phosphodiesterases and cardiac cGMP: evolving roles and controversies","volume":"32","author":"Zhang","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.vph.2012.09.001_bb0635","first-page":"H622","article-title":"Adrenomedullin activity in chronically hypoxic rat lungs","volume":"271","author":"Zhao","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.vph.2012.09.001_bb0640","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/hc2901.093117","article-title":"Sildenafil inhibits hypoxia-induced pulmonary hypertension","volume":"104","author":"Zhao","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0645","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/01.CIR.0000050653.10758.6B","article-title":"Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity","volume":"107","author":"Zhao","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2012.09.001_bb0650","doi-asserted-by":"crossref","first-page":"12051","DOI":"10.1074\/jbc.M413611200","article-title":"Structural and functional features in human PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and regulation","volume":"280","author":"Zoraghi","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2012.09.001_bb0655","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1161\/CIRCULATIONAHA.109.891077","article-title":"Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation","volume":"121","author":"Zuckerbraun","year":"2010","journal-title":"Circulation"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718911200184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153718911200184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T10:48:34Z","timestamp":1744109314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153718911200184X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":129,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S153718911200184X"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2012.09.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}